https://www.selleckchem.com/pr....oducts/cfi-402257.ht
70 μM). Complex 1 was shown as a potent XO inhibitor, with an IC50 value of 19.33 μM, and the binding mode with the enzyme was predicted by molecular docking. Its inhibitory activity against XO is a potential advantage that might result in improved profile and anticancer activity. © 2020 Deutsche Pharmazeutische Gesellschaft.AIMS To analyse days absent from work related to individual microvascular, macrovascular, and other complications of type 2 diabetes (T2D) and to identify key drivers of absence. MATERIALS AND METHODS National he
Aimer
Commentaire
Partagez
